Radiobiological Evaluation of Three Common Clinical Radiotherapy Techniques Including Combined Photon-Electron, Tangential Beams and Electron Therapy in Left-Sided Mastectomy Patients

Document Type : Original Article


1 Department of Medical Physics, School of Medicine, Isfahan, Iran

2 Department of Radiotherapy and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


Background: The aim of this study was radiobiological evaluation of different radiotherapy (RT) techniques, namely, combined photon-electron, two tangential photon beams, and electron therapy which are commonly used for treatment of mastectomy patients. Materials and Methods: The mentioned techniques were planned on the computed tomography (CT) images of a chest phantom, using TiGRT treatment planning system (TPS). The TPS dose calculations were verified using Thermo Luminescence dosimeters (TLD) measurements. Dose-volume histogram (DVH) of the plans was generated in the TPS, and also tumor control probability (TCP) and normal tissue complication probability (NTCP) values were calculated using DVH data for each technique. For TCP and NTCP modeling, Poisson Linear-Quadatric (PLQ) and Lyman-Kutcher-Burman (LKB) models were used, respectively. Results: The TCPs for the chest wall, internal mammary nodes, supraclavicular nodes, and axilla for the combined photon-electron was 90%, 90%, 90%, and 65%, respectively, which was higher compared to tangential beams (up to 11%, 11%, 5%, and 5%, respectively) and the electron therapy (up to 11%, 11%, 33%, and 23%, respectively) Whereas the NTCPs of the tangential beams for ipsilateral and contralateral lungs, heart, and chest wall–lung interface was 4%, 1%, 3%, and 5.6%, respectively. These NTCP values were considerably lower than electron therapy (up to 42%, 66%, and 40% and 30%, respectively) and combined photon-electron (up to 55%, 75%, 50%, and 20%, respectively) methods. Conclusion: Tangential beam is suggested for treating mastectomy patients, due to sufficient value of TCP, and also lower NTCP compared to the other techniques such as electron therapy and combined photon-electron.


Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med 1997;337:949-55.  Back to cited text no. 1
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.  Back to cited text no. 2
Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:1220-9.  Back to cited text no. 3
Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA, et al. The future of radiation oncology in the United States from 2010 to 2020: Will supply keep pace with demand? J Clin Oncol 2010;28:5160-5.  Back to cited text no. 4
Dessena M, Dessi M, Demontis B, Grosso LP, Porru S, Meleddu GF, et al. Exclusive intra-operative radiation therapy (IORT) for early stage breast cancer: Pilot study of feasibility. G Chir 2011;32:104-9.  Back to cited text no. 5
Menard J, Campana F, Kirov KM, Bollet MA, Dendale R, Fournier-Bidoz N, et al. Radiotherapy for breast cancer and pacemaker. Cancer Radiother 2011;15:197-201.  Back to cited text no. 6
Jereczek-Fossa BA, Santoro L, Colangione SP, Morselli L, Fodor C, Vischioni B, et al. Electronic portal imaging registration in breast cancer radiotherapy verification: Analysis of inter-observer agreement among different categories of health practitioners. Neoplasma 2013;60:302-8.  Back to cited text no. 7
Alford SL, Prassas GN, Vogelesang CR, Leggett HJ, Hamilton CS. Adjuvant breast radiotherapy using a simultaneous integrated boost: Clinical and dosimetric perspectives. J Med Imaging Radiat Oncol 2013;57:222-9.  Back to cited text no. 8
Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 1989;40:204-8.  Back to cited text no. 9
Khan FM, Gibbons JP. Khan's the Physics of Radiation Therapy. Minnesota, USA: Lippincott Williams & Wilkins; 2014.  Back to cited text no. 10
Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 2003;97:1404-11.  Back to cited text no. 11
Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003;89:840-6.  Back to cited text no. 12
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.  Back to cited text no. 13
Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010;102:220-6.  Back to cited text no. 14
Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 2007;7:9.  Back to cited text no. 15
Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2002;52:406-14.  Back to cited text no. 16
Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419-24.  Back to cited text no. 17
Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A, et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ 2003;326:256-7.  Back to cited text no. 18
Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010;76:S77-85.  Back to cited text no. 19
Bouyeh KA, Shokrani P, Amouheidari AR, Roayaei M. Evaluation of different treatment planning of breast cancer patients to estimate complications probability of lung and heart. J Isfahan Med Sch. (In Press).  Back to cited text no. 20
Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003;55:724-35.  Back to cited text no. 21
Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13-9.  Back to cited text no. 22
Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.  Back to cited text no. 23
Warkentin B, Stavrev P, Stavreva N, Field C, Fallone BG. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. J Appl Clin Med Phys 2004;5:50-63.  Back to cited text no. 24
Salem A, Mohamad I, Dayyat A, Kanaa'n H, Sarhan N, Roujob I, et al. Combined photon-electron beams in the treatment of the supraclavicular lymph nodes in breast cancer: A novel technique that achieves adequate coverage while reducing lung dose. Med Dosim 2015;40:210-7.  Back to cited text no. 25
Prasad SC, Bedwinek JM, Gerber RL. Lung dose in electron beam therapy of chest wall. Acta Radiol Oncol 1983;22:91-5.  Back to cited text no. 26
Tavakoli MB, Taheri H, Akhavan A. Evaluation of calculation errors of treatment planning system in dose distribution of electron beams of 3D-CRT inside the lung. J Isfahan Med Sch 2017;35:900-4.  Back to cited text no. 27
Muren LP, Maurstad G, Hafslund R, Anker G, Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002;62:173-83.  Back to cited text no. 28
Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002;62:163-71.  Back to cited text no. 29